Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey

Celik I., Mandel N. M. , Gokmen E. , Unal O. U. , Sevinc A., Coskun H. S. , ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • City: Illinois
  • Country: United States Of America